Adagene Inc. (ADAG)

↓ Download CSV

CIK 0001818838 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated E9
  • Fiscal year ends Dec 31

In fiscal 2025, Adagene Inc. reported revenue of $7.67M, up 7332.8% from the prior year. The company ran a net loss, with a net margin of -229.6%. It held $78.26M in total assets against $26.36M in total liabilities.

Key ratios (FY2025)

-279.5%
Operating margin
-229.6%
Net margin
-49.8%
Return on equity
+7332.8%
Revenue growth (YoY)
Metric (FY)202520242023202220212020201920182017
Revenue$7.67M$103.2K$18.11M$9.29M$10.18M$700.9K$480.0K$1.51M
Operating Income-$21.44M-$35.95M-$23.72M-$83.92M-$72.36M-$43.15M-$19.17M-$17.33M
Net Income-$17.61M-$33.42M-$18.95M-$79.97M-$73.18M-$42.40M-$16.43M-$15.27M
EPS (Diluted)$-0.30$-0.59$-0.35$-1.48$-1.46$-2.67$-1.10$-0.94
Total Assets$78.26M$89.27M$115.73M$152.40M$189.51M$84.26M$105.89M
Total Liabilities$26.36M$38.74M$45.17M$69.31M$32.95M$19.20M$8.70M
Shareholders' Equity$35.35M$50.52M$70.56M$83.09M$156.56M-$89.39M-$57.01M-$41.03M-$25.65M
Cash & Equivalents$74.52M$85.19M$109.93M$143.76M$174.39M$75.15M$92.53M
Operating Cash Flow-$15.66M-$29.70M-$28.45M-$48.61M-$43.41M-$28.53M-$18.15M-$14.26M
Capital Expenditures$17.1K$33.6K$85.0K$690.9K$2.51M$935.2K$151.8K$514.7K
Shares Outstanding59.01M56.29M54.74M54.14M50.03M15.95M15.18M15.16M